arrow
M

Matthew B. McNeil

University of Otago
H指数:22
被引数:1,195

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genome scale CRISPRi reveals both shared and strain-specific vulnerabilities in genetically diverse drug-resistant strains of Mycobacterium tuberculosis

基因组规模CRISPRi揭示基因多样性结核分枝杆菌耐药菌株中共享和菌株特异性的脆弱性

2026-06-010
OA
Dormancy regulon reduction was pivotal to the evolution of Mycobacterium tuberculosis

休眠调控子减少对结核分枝杆菌的进化至关重要

2026-04-130
OAAI
ClpC1-targeting peptide natural products differentially dysregulate the proteome of Mycobacterium tuberculosis

ClpC1-targeting肽天然产物差异调节结核分枝杆菌蛋白质组

2026-01-290
OA
Advancing the antituberculosis activity of nitropicolinic acids and amides

推进硝基吡嗪甲酸及其酰胺的抗结核活性

2025-10-290
OAAI
Whole genome CRISPRi screening identifies druggable vulnerabilities in an isoniazid resistant strain of Mycobacterium tuberculosis

全基因组CRISPRi筛选鉴定了耐异烟肼结核分枝杆菌菌株的可药物靶点脆弱性

2024-11-135
OA
Identification of Chemical Scaffolds That Inhibit the Mycobacterium tuberculosis Respiratory Complex Succinate Dehydrogenase

抑制结核分枝杆菌呼吸复合琥珀酸脱氢酶的化学支架的鉴定

2024-09-131
PRE
A dual-targeting succinate dehydrogenase and F1Fo-ATP synthase inhibitor rapidly sterilizes replicating and non-replicating Mycobacterium tuberculosis
2024-04-017
PRE
An amiloride derivative is active against the F1Fo-ATP synthase and cytochrome bd oxidase of Mycobacterium tuberculosis
2022-02-2427
OAAI